Search clinical trials for: DVS-233 SR
Total 3548 results
-
Groupe Francophone des MyelodysplasiesActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesFrance
-
BeiGeneCompleted
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Metastatic Melanoma | Advanced Non-hematologic MalignanciesUnited States
-
Quigley Pharma, Inc.CompletedDiabetic NeuropathyUnited States
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of
-
GEN İlaç ve Sağlık Ürünleri A.Ş.Sulfateq B.V.Recruiting
-
Cerevel Therapeutics, LLCCompleted
-
Functional Neuromodulation LtdActive, not recruitingAlzheimer DiseaseUnited States, Canada, Germany
-
Watching Over Mothers & Babies FoundationUniversity of ArizonaCompleted
-
Kallyope Inc.Active, not recruitingObesity | Type 2 Diabetes Mellitus (T2DM)United States
-
Stanford UniversityRecruitingParkinson DiseaseUnited States
-
M.D. Anderson Cancer CenterBayer; Prostate Cancer FoundationCompleted
-
St. Joseph's Hospital and Medical Center, PhoenixTerminatedParkinson's Disease | Dementia | Mild Cognitive ImpairmentUnited States
-
GGZ CentraalUniversity Medical Center Groningen; Maastricht UniversityTerminatedTardive Dyskinesia | Tardive DystoniaNetherlands
-
Xuanwu Hospital, BeijingPeking University; Beijing Tiantan Hospital; Qilu Hospital of Shandong University and other collaboratorsRecruitingEpilepsy, Drug ResistantChina
-
Ruijin HospitalNot yet recruitingRelapsed or Refractory B-cell LymphomaChina
-
Ochsner Health SystemUnited TherapeuticsCompletedCritical Limb IschemiaUnited States
-
PfizerCompletedDepressive Disorder, MajorUnited States
-
Aerie PharmaceuticalsAlcon ResearchRecruitingNeovascular Age-related Macular Degeneration (nAMD)United States
-
The University of Hong KongThe Boys' and Girls' Clubs Association of Hong KongCompleted
-
Hoffmann-La RocheCompleted
-
VA Office of Research and DevelopmentCompleted
-
Beijing InnoCare Pharma Tech Co., Ltd.Recruiting
-
Blueprint Medicines CorporationRecruitingIndolent Systemic Mastocytosis | Monoclonal Mast Cell Activation SyndromeUnited States, Spain, Australia, France, Netherlands, Switzerland, Norway, United Kingdom, Austria, Belgium, Germany, Italy, Portugal
-
AmgenActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, Czechia, Taiwan, Canada, Japan, Korea, Republic of, Germany, Hungary, Australia, Hong Kong, Spain, Poland
-
Protagonist Therapeutics, Inc.Completed
-
Kartos Therapeutics, Inc.UnknownPolycythemia VeraUnited States, Poland, Spain, Germany, Hungary, France
-
AmgenTerminated
-
AmgenCompletedMigraineUnited States
-
Gilead SciencesCompleted
-
University of Southern CaliforniaRecruitingParkinson DiseaseUnited States
-
AmgenCompleted
-
Kallyope Inc.CompletedObesity | Type 2 Diabetes Mellitus in ObeseUnited States
-
Henry Ford Health SystemAmerican Academy of Cosmetic SurgeryCompletedPost Surgical ScarsUnited States
-
Massachusetts General HospitalUniversity of Miami; Fenway Community HealthCompletedStress Disorders, Post-Traumatic | Sexual Risk Behavior | Childhood Sexual AbuseUnited States
-
AmgenCompletedObesityUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingLymphomas | B-cell LymphomasUnited States
-
Homology Medicines, IncWithdrawnMucopolysaccharidosis IIUnited States, Canada
-
Kartos Therapeutics, Inc.TerminatedSmall Cell Lung Carcinoma | Small-cell Lung Cancer | Small Cell Lung Cancer Extensive Stage | Small Cell Lung Cancer RecurrentGermany, Spain, France, Australia, United States, Korea, Republic of, Hungary
-
TWi Biotechnology, Inc.CompletedInherited Epidermolysis BullosaTaiwan
-
AbbVieCompleted
-
AmgenCompletedEnd Stage Renal Disease | Chronic Kidney Disease | Kidney Disease | Hyperphosphatemic
-
GlycadiaUniversity of FloridaCompleted
-
Genus Oncology, LLCCompletedSolid TumorsUnited States
-
Boehringer IngelheimCompletedAlzheimer DiseaseUnited States, Canada
-
4SC AGCompleted
-
AbbottAbbott Japan Co.,LtdCompleted
-
AbbottCompleted
-
National Institute on Drug Abuse (NIDA)CompletedTobacco Use Disorder | Tobacco Use CessationUnited States
-
ICM Co. Ltd.Not yet recruiting